Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes

被引：0
|
作者：
Zemanova, Zuzana [1 ,2 ]
Michalova, Kyra [1 ,2 ]
Brezinova, Jana [3 ]
Lhotska, Halka [1 ,2 ]
Svobodova, Karla [1 ,2 ]
Sarova, Iveta [3 ]
Lizcova, Libuse [1 ,2 ]
Izakova, Silvia [1 ,2 ]
Ransdorfova, Sarka [3 ]
Krejcik, Zdenek [3 ]
Belickova, Monika [3 ]
Siskova, Magda [1 ,2 ]
Jonasova, Anna [4 ]
Neuwirtova, Radana [2 ,5 ]
Zmolikova, Jana [6 ]
Cermak, Jaroslav [3 ]
机构：
[1] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[3] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[4] Charles Univ Prague, Dept Med 1, Gen Hosp, Prague, Czech Republic
[5] Charles Univ Prague, Gen Univ Hosp, Dept Med 1, Prague, Czech Republic
[6] CGB Lab, Ostrava, Czech Republic
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Treatment and outcome of 23 paediatric patients with myelodysplastic syndromes (MDS)
    Polychronopoulou, S
    Panagiotou, JP
    Papadakis, V
    Parcharidou, A
    Psiachou, H
    Mavrou, A
    Haidas, S
    LEUKEMIA, 2000, 14 (05) : 969 - 969
  • [42] Phase II study of amifostine in patients with myelodysplastic syndromes (MDS).
    List, AF
    Holmes, H
    Greenberg, PL
    Bennett, JM
    Oster, W
    BLOOD, 1999, 94 (10) : 305A - 305A
  • [43] Clinical Experience of Decitabine in Elderly Patients with Myelodysplastic Syndromes (MDS)
    Geils, George F., Jr.
    BLOOD, 2009, 114 (22) : 1092 - 1092
  • [44] Improvement in cytopenias of patients with myelodysplastic syndromes (MDS) in response to thalidomide
    Raza, A
    Lisak, L
    Little, L
    Andrews, C
    Meyer, P
    Ekbal, M
    Venugopal, P
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 103 - 104
  • [45] THE IMPACT OF MYELODYSPLASTIC SYNDROMES (MDS) ON THE MENTAL HEALTH OF PATIENTS AND CAREGIVERS
    Scheurmeyer, Isabel
    Hughes, Mary
    Sloan, Erika
    LeBlanc, Thomas
    Houk, Alice
    Sirewu, Nyaradzo
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
  • [46] Combination of thalidomide and Enbrel for the treatment of patients with myelodysplastic syndromes (MDS).
    Raza, A
    Dutt, D
    Lisak, L
    Dean, L
    Fantroy, L
    Gezer, S
    Syed, E
    Goldberg, C
    Loew, J
    Hsu, WT
    Venugopal, P
    BLOOD, 2001, 98 (11) : 273B - 274B
  • [47] CLASSIFICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)
    CATOVSKY, D
    MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 3 - 3
  • [48] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES (MDS)
    TRICOT, G
    VLIETINCK, R
    HENDRICKX, B
    VERWILGHEN, RL
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 362 - 362
  • [49] IMMUNOTHERAPY STRATEGIES IN MYELODYSPLASTIC SYNDROMES (MDS)
    Gill, Saar
    LEUKEMIA RESEARCH, 2021, 108 : S57 - S57
  • [50] Cyclosporin A in the treatment of myelodysplastic syndromes (MDS)
    Shirin, AD
    Volkova, MA
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 416 - 416
12345